1. Academic Validation
  2. Design, synthesis, and biological evaluation of benzo[b]thiophene 1,1-dioxide derivatives as potent STAT3 inhibitors

Design, synthesis, and biological evaluation of benzo[b]thiophene 1,1-dioxide derivatives as potent STAT3 inhibitors

  • Chem Biol Drug Des. 2021 Nov;98(5):835-849. doi: 10.1111/cbdd.13939.
Wen-Zhen Li 1 Hui-Zhi Xi 1 Yi-Jie Wang 1 Hong-Bo Ma 2 Zhi-Qiang Cheng 3 Yu Yang 1 Meng-Ling Wu 1 Ting-Mei Liu 1 Wen Yang 1 Qin Wang 1 Meng-Ya Liao 4 Yong Xia 1 Yi-Wen Zhang 1
Affiliations

Affiliations

  • 1 Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • 2 West China School of Pharmacy, Sichuan University, Chengdu, China.
  • 3 Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • 4 Center of Gerontology and Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
Abstract

As a member of the signal transducer and activator of transcription (STAT) family, STAT3 plays a critical role in several biological pathways such as cell proliferation, migration, survival, and differentiation. Due to abnormal continuous activation in tumors, inhibition of STAT3 has emerged as an attractive approach for the treatment of various Cancer cells. Herein, we report a series of novel STAT3 inhibitors based on benzo[b]thiophene 1,1-dioxide scaffold and evaluated their Anticancer potency. Among them, compound 8b exhibited the best activity against Cancer cells. Compound 8b induced Apoptosis and blocked the cell cycle. Meanwhile, 8b reduced intracellular ROS content and caused the loss of mitochondrial membrane potential. Further research revealed that 8b significantly blocked STAT3 phosphorylation and STAT3-dependent dual-luciferase reporter gene experiments showed that compound 8b has a marked inhibition of STAT3-mediated Firefly luciferase activity. Molecular modeling studies revealed compound 8b occupied the pocket well with the SH2 domain in a favorable conformation.

Keywords

ROS; STAT3; apoptosis; cell cycle; inhibitors; mitochondrial membrane potential; tumors.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-164533
    STAT3 Inhibitor